India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,427 LV Subba Reddy & family ₹1,500 Cr
Revenue · FY 2025
₹310.45 Cr
▲ 11% YoY
Net profit · FY 2025
₹14.58 Cr
Net margin 4.7%
EBITDA · FY 2025
₹25.45 Cr
EBITDA margin 8.2%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹8 Cr
Issued & subscribed
Open charges
₹31.9 Cr
Satisfied ₹1.51 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
409
Provident fund records
About Saraca Laboratories Limited
Data last updated:
Saraca Laboratories Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 January 1988 and has been in existence for over 38 years.
Its director LV Subba Reddy and family are #1,427 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85195TG1988PLC008172. Its GSTIN is 36AACCS8240H1ZB (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹8 Cr. It was formerly known as Suraca Laboratories P Ltd and Saraca Laboratories Private Limited. It is led by directors including Puthana Reddy Subramanyam (Managing Director) and Lingareddy Subba Reddy Venkata (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.320 1st Floor Swamy Ayyappa Co – Operative Housing Society Ltd Maadhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹310.45 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹14.58 Cr (net margin 4.7%) and EBITDA of ₹25.45 Cr (EBITDA margin 8.2%). Revenue has declined at a compounded annual rate (CAGR) of 2% over five years.
The company has about 409 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Saraca. As per MCA filings, the company has open charges of ₹31.9 Cr and satisfied charges of ₹1.51 Cr on record. Court records list 21 cases involving the company, including 19 filed by the company and 2 filed against it; 5 cases are pending. The company has 7 deals on record (7 secondary share transfers); the latest was in September 2017. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is SCL Lifesciences Limited with revenue of ₹340.47 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saraca.com.
Company details
CIN U85195TG1988PLC008172
Registration Number 008172
Incorporation Date 11 January 1988
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Name history
Saraca Laboratories has undergone 3 name changes throughout its history. The company was previously known as Suraca Laboratories P Ltd, Saraca Laboratories Private Limited, and Vcr Drugs Private Limited. The current legal name is Saraca Laboratories Limited.
| Company Name | Status |
|---|---|
| Saraca Laboratories Limited | Current |
| Suraca Laboratories P Ltd | Previous |
| Saraca Laboratories Private Limited | Previous |
| Vcr Drugs Private Limited | Previous |
CIN history
Saraca Laboratories has one previous CIN (Corporate Identification Number): U85195AP1988PLC008172. The current CIN is U85195TG1988PLC008172, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85195TG1988PLC008172 | Current |
| U85195AP1988PLC008172 | Previous |
Key People
Puthana Reddy Subramanyam Managing Director Lingareddy Subba Reddy Venkata Whole-Time Director Sree Phani Kumar Reddy Mallidi Director Recognitions & Rankings of Saraca Laboratories
Contact details
Saraca Laboratories Limited's registered office is in Hyderabad, Telangana. Its website is saraca.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.320 1st Floor Swamy Ayyappa Co – Operative Housing Society Ltd Maadhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Saraca Laboratories Limited, buy the company report.
Comprehensive company report
Saraca Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Saraca Laboratories operates one associated brand: Saraca. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures Active Pharmaceutical Ingredients and Intermediates for export. | saraca.com |
Business activity
The main business activity of Saraca Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Saraca Laboratories Limited, buy the company report.
Financials of Saraca Laboratories Limited
FY 2025 filings availableSaraca Laboratories Limited reported revenue of ₹310.45 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹310.45 Cr ▲ 11%
Net profit · FY 2025
₹14.58 Cr margin 4.7%
EBITDA · FY 2025
₹25.45 Cr margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
5 years · compounded
▼ 2%
EBITDA CAGR growth
3 years · compounded
▲ 146%
5 years · compounded
▲ 6%
Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saraca Laboratories Limited, buy the company report.
Board of directors and KMP of Saraca Laboratories Limited
Saraca Laboratories Limited currently reports 8 directors and 1 key managerial person. 3 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sree Phani Kumar Reddy Mallidi Also directs: Andhra Organics Limited, Amulya Energy Private Limited, Amala Energy Private Limited and 5 more | Director | 09 May 1997 | 29 Years 5 Months | Current |
| Shailesh Shivappa Biradar Also directs: Hise Agencies Private Limited | Company Secretary | 11 Jun 2019 | 7 Years 4 Months | Current |
| Puthana Reddy Subramanyam Also directs: Indus Medi Supplies LLP, PSR Soft Labs Private Limited | Managing Director | 16 Dec 1994 | 31 Years 10 Months | Current |
| Prasanth Nandigala Also directs: Virchow Laboratories Limited, Andhra Organics Limited, Virchow Biotech Private Limited and 5 more | Director | 04 Nov 2014 | 11 Years 11 Months | Current |
| Venkata Sunil Lingareddy | Director | 06 Apr 2000 | 26 Years 6 Months | Current |
| Gargi Pammi Also directs: Coramandel Mining & Exports Private Limited, Mukunda Dairy Products Private Limited, Virchow Laboratories Limited and 3 more | Director | 29 Sep 2017 | 9 Years 0 Months | Current |
Showing 6 of 9 current directors and KMP. View all directors and KMP
Peer comparison
Saraca Laboratories Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SCL Lifesciences Limited | ₹340.47 Cr (FY 2025) | -4.0% | Punjab, India | |||
| Valiant Laboratories Limited | ₹338.77 Cr (FY 2023) | 61.0% | Mumbai, Maharashtra, India | |||
| Mehta Api Private Limited | ₹325.77 Cr (FY 2025) | 36.0% | Mumbai, Maharashtra, India | |||
| Synergene Active Ingredients Private Limited | ₹319.93 Cr (FY 2024) | 37.0% | Hyderabad, Telangana, India | |||
| Mangalam Drugs and Organics Limited | ₹318.73 Cr (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Saraca Laboratories Limitedthis company | ₹310.45 Cr (FY 2025) | ₹14.58 Cr | 4.7% | 11.0% | 409 | Hyderabad, Telangana, India |
| Megafine Pharma Private Limited | ₹310.01 Cr (FY 2025) | -5.0% | Mumbai, Maharashtra, India | |||
| Bal Pharma Limited | ₹305.29 Cr (FY 2025) | -11.0% | Bangalore, Karnataka, India | |||
| Optrix Laboratories Private Limited | ₹304.7 Cr (FY 2020) | 43.0% | Hyderabad, Telangana, India | |||
| Ajinomoto Bio-Pharma Services India Private Limited | ₹301.41 Cr (FY 2025) | 56.0% | Anakapalle, Andhra Pradesh, India | |||
| Alembic Limited | ₹296.78 Cr (FY 2025) | 40.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Saraca Laboratories Limited, buy the company report.
Auditor
Saraca Laboratories Limited is audited by P. Murali & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P. Murali & Co | FY 2023 | 007257S |
Shareholding
The shareholding of Saraca Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Saraca Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹31.9 Cr
Satisfied charges
₹1.51 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2022 | 100607628 | Hdfc Bank Limited | ₹39.59 Lakh | Open | |
| 30 Aug 1994 | 90118489 | Sbicap Trustee Company Limited | ₹31.5 Cr | Open | |
| 28 Mar 2000 | 90118968 | State Bvank of Hyderabad | ₹4 Lakh | Satisfied | |
| 16 Mar 2000 | 90118966 | State Bank of Hyderabad | ₹50 Lakh | Satisfied | |
| 19 Apr 1996 | 90114045 | State Bank of Hyderabad | ₹47 Lakh | Satisfied |
To see the full charge records of Saraca Laboratories Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Saraca Laboratories Limited has 7 deals on record (7 secondary share transfers); the latest was in September 2017.
Total deals
7
Secondary share transfers
7
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Others-SARACA LABORATORIES LIMITED, an individual |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: Narayana Reddy M Huf, 3 individuals Seller: Others-SARACA LABORATORIES LIMITED, 3 individuals |
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Others-SARACA LABORATORIES LIMITED, 3 individuals |
| Sep 2011 | Secondary share transfer | Undisclosed | Buyer: Others-SARACA LABORATORIES LIMITED, 3 individuals Seller: 4 individuals |
To see the full deal history of Saraca Laboratories Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Saraca Laboratories Limited has 21 court cases on record: 19 filed by Saraca Laboratories, 2 filed against it. 5 cases are pending and 16 are disposed.
Total cases
21
Filed by the company
19
Filed against the company
2
Pending
5
Disposed
16
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 20 | 2 | 4 |
| District courts | 1 | 0 | 1 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed by the company against M/S Citizenplus Pharmaceuticals Pvt Ltd | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Southern Power Distribution Company of Telangana Ltd., and 2 others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Union of India and 1 other | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Telangana State Southern Power Distribution Company Limited and 2 others | Pending |
| High Court | Criminal complaint | Filed by the company against individuals | Pending |
To see the full case history of Saraca Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Saraca Laboratories Limited was last rated by Crisil on 13 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 13 Oct 2020 |
To see the full credit ratings and regulatory alerts of Saraca Laboratories Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saraca Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Saraca Laboratories Limited has a workforce of 409 employees on its EPFO records as of Apr 06, 2024, across 2 active EPFO establishments.
Employee count
409
Active EPFO establishments
2
Employee growth
-10.89%
GST
Saraca Laboratories has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS8240H1ZB | Telangana | Active | 01 Jul 2017 |
| 37AACCS8240H1Z9 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Saraca Laboratories Limited, buy the company report.
Recent activity
Saraca Laboratories Limited has 11 board changes on record since 1992: 9 appointments and 2 cessations. The latest: Shailesh Shivappa Biradar was appointed as Company Secretary on 11 Jun 2019.
AGM
Saraca Laboratories Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Saraca Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 31.50 Cr registered on 30 Aug 1994 with Charge ID 90118489 was modified on 26 Dec 2024.
Charges
A charge registered on 10 Jun 1991 via Charge ID 90119402 with Andhra Bank was fully satisfied on 28 Aug 2023.
Charges
A charge registered on 10 Jan 1991 via Charge ID 90118356 with A P S F C. Hyderabad was fully satisfied on 03 Feb 2023.
Charges
A charge registered on 28 Mar 2000 via Charge ID 90118968 with State Bvank Of Hyderabad was fully satisfied on 16 Nov 2022.
Charges
A charge registered on 16 Mar 2000 via Charge ID 90118966 with State Bank Of Hyderabad was fully satisfied on 16 Nov 2022.
Charges
A charge registered on 19 Apr 1996 via Charge ID 90114045 with State Bank Of Hyderabad was fully satisfied on 16 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100607628 was registered on 27 Aug 2022.
Appointed
Shailesh Shivappa Biradar was appointed as Company Secretary.
Appointed
Gargi Pammi was appointed as Director.
Ceased
Hemanth Nandigala ceased to be Additional Director.
15 earlier events are in the company report.
Frequently asked questions
Saraca Laboratories is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 January 1988 (38+ years old) and is registered under CIN U85195TG1988PLC008172.
Saraca Laboratories has 9 current directors and KMP:
- Puthana Reddy Subramanyam - Managing Director
- Lingareddy Subba Reddy Venkata - Whole-Time Director
- Sree Phani Kumar Reddy Mallidi - Director
- Prasanth Nandigala - Director
- Venkata Sunil Lingareddy - Director
- Gargi Pammi - Director
- Mundla Maha Vishnu - Director
- Hemanth Nandigala - Director
- Shailesh Shivappa Biradar - Company Secretary
The latest financial statements of Saraca Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Saraca Laboratories is 36AACCS8240H1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AACCS8240H1Z9 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Saraca Laboratories is U85195TG1988PLC008172. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saraca Laboratories has 21 court cases on record: 19 filed by the company and 2 filed against it. 5 are pending. Most are in the high courts.
Saraca Laboratories was incorporated on 11 January 1988, making it 38+ years old. It is registered with the Registrar of Companies, Hyderabad.
Saraca Laboratories has 7 deals on record (7 secondary share transfers); the latest was in September 2017.
The peers of Saraca Laboratories by revenue are SCL Lifesciences Limited, Valiant Laboratories Limited, Mehta Api Private Limited, Synergene Active Ingredients Private Limited, Mangalam Drugs and Organics Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shailesh Shivappa Biradar was appointed as Company Secretary on 11 Jun 2019. Gargi Pammi was appointed as Director on 29 Sep 2017. Hemanth Nandigala ceased to be Additional Director on 30 Sep 2015. Saraca Laboratories has 11 board changes on record in total.
Saraca Laboratories can be reached through the website saraca.com. Its registered office is in Hyderabad, Telangana, India.